Just: Evotec completes acquisition of Just Biotherapeutics

Evotec announced that the strategic transaction to acquire Just Biotherapeutics, signed on 20 May 2019, has been completed. The acquisition accelerates Evotec's long-term strategy to be the industry partner of choice for external end-to-end innovation, strengthening Evotec's multimodality approach to R and D.